Benjamin Hickey - Net Worth and Insider Trading

Benjamin Hickey Net Worth

The estimated net worth of Benjamin Hickey is at least $7 Million dollars as of 2026-09-10. Benjamin Hickey is the EVP, Chief Commercial Officer of Mirati Therapeutics Inc and owns about 117,028 shares of Mirati Therapeutics Inc (MRTX) stock worth over $7 Million. Benjamin Hickey is also the President, RayzeBio Org. of Bristol-Myers Squibb Co and owns about 8,789 shares of Bristol-Myers Squibb Co (BMY) stock worth over $566,099. Details can be seen in Benjamin Hickey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Benjamin Hickey has not made any transactions after 2025-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Benjamin Hickey

To

Benjamin Hickey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Benjamin Hickey owns 5 companies in total, including Mirati Therapeutics Inc (MRTX) , Halozyme Therapeutics Inc (HALO) , and Surface Oncology Inc (SURF) among others .

Click here to see the complete history of Benjamin Hickey’s form 4 insider trades.

Insider Ownership Summary of Benjamin Hickey

Ticker Company Transaction Date Type of Owner
MRTX Mirati Therapeutics Inc 2024-01-16 EVP & Chief Commercial Officer
HALO Halozyme Therapeutics Inc 2019-10-01 SVP & Chief Commerical Officer
SURF Surface Oncology Inc 2021-12-09 director
LIMIT LIMIT 2023-10-31 director
LIMIT LIMIT 2024-02-26 President & RayzeBio Org.

Benjamin Hickey Latest Holdings Summary

Benjamin Hickey currently owns a total of 2 stocks. Among these stocks, Benjamin Hickey owns 117,028 shares of Mirati Therapeutics Inc (MRTX) as of January 16, 2024, with a value of $7 Million and a weighting of 92.39%. Benjamin Hickey also owns 8,789 shares of Bristol-Myers Squibb Co (BMY) as of May 9, 2025, with a value of $566,099 and a weighting of 7.61%.

Latest Holdings of Benjamin Hickey

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRTX Mirati Therapeutics Inc 2024-01-16 117,028 58.70 6,869,544
BMY Bristol-Myers Squibb Co 2025-05-09 8,789 64.41 566,099

Holding Weightings of Benjamin Hickey


Benjamin Hickey Form 4 Trading Tracker

According to the SEC Form 4 filings, Benjamin Hickey has made a total of 8 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 1,597 shares on January 16, 2024, which brought Benjamin Hickey around $94,255.

According to the SEC Form 4 filings, Benjamin Hickey has made a total of 1 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Bristol-Myers Squibb Co is the sale of 97 shares on May 9, 2025, which brought Benjamin Hickey around $3,702.

Insider Trading History of Benjamin Hickey

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Benjamin Hickey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Benjamin Hickey owns.
View MRTX Analysis

Benjamin Hickey Ownership Network

Ownership Network List of Benjamin Hickey

No Data

Ownership Network Relation of Benjamin Hickey

Insider Network Chart


Benjamin Hickey Owned Company Details

What does Mirati Therapeutics Inc do?

Who are the key executives at Mirati Therapeutics Inc?

Benjamin Hickey is the EVP & Chief Commercial Officer of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include Sr. Vice President & Chief Scie Jamie Christensen , Interim CFO Aaron Ondrey , and other: See remarks Mva Investors, Llc .

Mirati Therapeutics Inc (MRTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mirati Therapeutics Inc (MRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mirati Therapeutics Inc Insider Transactions

No Available Data

Benjamin Hickey Mailing Address

Above is the net worth, insider trading, and ownership report for Benjamin Hickey. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Benjamin Hickey's mailing address is: Princeton Nj 08543.